↓ Skip to main content

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
4 X users
patent
1 patent

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells
Published in
Frontiers in Pharmacology, September 2022
DOI 10.3389/fphar.2022.963066
Pubmed ID
Authors

Gregory Gauthier-Coles, Angelika Bröer, Malcolm Donald McLeod, Amee J. George, Ross D. Hannan, Stefan Bröer

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 17%
Student > Ph. D. Student 1 8%
Student > Bachelor 1 8%
Student > Master 1 8%
Unknown 7 58%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 8%
Immunology and Microbiology 1 8%
Medicine and Dentistry 1 8%
Neuroscience 1 8%
Chemistry 1 8%
Other 0 0%
Unknown 7 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2024.
All research outputs
#6,575,802
of 25,784,004 outputs
Outputs from Frontiers in Pharmacology
#2,864
of 20,009 outputs
Outputs of similar age
#116,341
of 436,894 outputs
Outputs of similar age from Frontiers in Pharmacology
#156
of 1,587 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 20,009 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,894 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 1,587 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.